Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory syncytial virus
Pharma
Pfizer plots new RSV filing with positive Abrysvo data in adults
With fresh data for Abrysvo in adults at higher risk of disease, the New York drugmaker is plotting a new approval filing.
Fraiser Kansteiner
Apr 9, 2024 6:45am
In year 2, Pfizer's RSV vax Abrysvo retains most of its efficacy
Feb 29, 2024 8:02am
Amid supply constraints, Sanofi has big ambitions for Beyfortus
Feb 1, 2024 9:59am
GSK CEO still sees plenty of 'headroom for growth' for RSV shot
Nov 30, 2023 4:32pm
Senate Democrats demand answers around Beyfortus shortage in US
Nov 20, 2023 2:06pm
GSK crushed Pfizer in first round of RSV vaccine showdown
Nov 1, 2023 10:43am